v3.26.1
Consolidated Statements of Changes in Equity - CAD ($)
Common shares
Reserves
Commitment to issue shares
Foreign currency reserve
Deficit
Total
Balance at Sep. 30, 2023 $ 7,219,766 $ 1,385,293 $ 46,319 $ (63,899) $ (8,514,482) $ 72,997
Balance (in shares) at Sep. 30, 2023 30,460,475          
Fair value reversal on expired stock options (291,893) 291,893
Share-based compensation 630,626 630,626
Net loss and comprehensive loss (368,832) (3,085,195) (3,454,027)
Bonus shares issued $ 46,500 46,500
Bonus shares issued (in shares) 75,000          
Private placement, net of share issue costs $ 12,163,457 24,923 12,188,380
Private placement, net of share issue costs (in shares) 50,514,222          
Shares issued – restructuring payment $ 91,094 91,094
Shares issued – restructuring payment (in shares) 146,923          
Exercise of warrants $ 3,750 3,750
Exercise of warrants (in shares) 25,000          
Balance at Sep. 30, 2024 $ 19,524,567 1,724,026 46,319 (432,731) (11,282,861) 9,579,320
Balance (in shares) at Sep. 30, 2024 81,221,620          
Bought deal equity financing, net of share issue costs $ 119,813,403 119,813,403
Bought deal equity financing, net of share issue costs (in shares) 48,330,000          
Exercise of warrants – shares to be issued 750,000 750,000
Fair value reversal on expired stock options (172,806) 172,806
Shares issued on exercise of warrants and stock options $ 630,569 (433,764) 196,805
Shares issued on exercise of warrants and stock options (in shares) 1,359,067          
Share-based compensation 2,285,246 2,285,246
Reclassification of commitment to issue shares to common shares 46,319 (46,319)
Net loss and comprehensive loss 1,103,007 (16,972,421) (15,869,414)
Balance at Dec. 31, 2025 $ 140,014,858 $ 3,402,702 $ 750,000 $ 670,276 $ (28,082,476) $ 116,755,360
Balance (in shares) at Dec. 31, 2025 130,910,687